Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Multi-Parametric Ultra-High Field MRI Protocol for Central Nervous System Malignancy

NCT04539574 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04539574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Multi-Parametric Ultra-High Field MRI Protocol for Central Nervous System Malignancy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
September 4, 2020
Completion date
April 26, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system neoplasm, glioma, metastatic malignant neoplasm in the central nervous system, metastatic malignant solid neoplasm